  Background: The current clinical workflow for esophageal gross tumor volume
(GTV) contouring relies on manual delineation of high labor-costs and interuser
variability. Purpose: To validate the clinical applicability of a deep learning
(DL) multi-modality esophageal GTV contouring model, developed at 1 institution
whereas tested at multiple ones. Methods and Materials: We collected 606
esophageal cancer patients from four institutions. 252 institution-1 patients
had a treatment planning-CT (pCT) and a pair of diagnostic FDG-PETCT; 354
patients from other 3 institutions had only pCT. A two-streamed DL model for
GTV segmentation was developed using pCT and PETCT scans of a 148 patient
institution-1 subset. This built model had the flexibility of segmenting GTVs
via only pCT or pCT+PETCT combined. For independent evaluation, the rest 104
institution-1 patients behaved as unseen internal testing, and 354 institutions
2-4 patients were used for external testing. We evaluated manual revision
degrees by human experts to assess the contour-editing effort. The performance
of the deep model was compared against 4 radiation oncologists in a multiuser
study with 20 random external patients. Contouring accuracy and time were
recorded for the pre-and post-DL assisted delineation process. Results: Our
model achieved high segmentation accuracy in internal testing (mean Dice score:
0.81 using pCT and 0.83 using pCT+PET) and generalized well to external
evaluation (mean DSC: 0.80). Expert assessment showed that the predicted
contours of 88% patients need only minor or no revision. In multi-user
evaluation, with the assistance of a deep model, inter-observer variation and
required contouring time were reduced by 37.6% and 48.0%, respectively.
Conclusions: Deep learning predicted GTV contours were in close agreement with
the ground truth and could be adopted clinically with mostly minor or no
changes.
